Cryo-Cell International (NYSEAMERICAN:CCEL) Stock Price Crosses Above Fifty Day Moving Average – Here’s Why
by Sarita Garza · The Markets DailyCryo-Cell International Inc. (NYSEAMERICAN:CCEL – Get Free Report)’s share price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $3.88 and traded as high as $4.32. Cryo-Cell International shares last traded at $3.53, with a volume of 11,067 shares.
Cryo-Cell International Trading Down 4.1%
The company has a market cap of $32.16 million, a price-to-earnings ratio of -13.30 and a beta of 0.47. The business has a 50-day moving average price of $3.89 and a 200 day moving average price of $3.62.
Cryo-Cell International (NYSEAMERICAN:CCEL – Get Free Report) last announced its earnings results on Wednesday, July 15th. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $7.78 million for the quarter.
Institutional Inflows and Outflows
An institutional investor recently raised its stake in Cryo-Cell International stock. Susquehanna International Group LLP lifted its position in Cryo-Cell International Inc. (NYSEAMERICAN:CCEL – Free Report) by 40.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,064 shares of the company’s stock after acquiring an additional 4,046 shares during the period. Susquehanna International Group LLP owned about 0.17% of Cryo-Cell International worth $45,000 as of its most recent SEC filing. Institutional investors and hedge funds own 10.44% of the company’s stock.
Cryo-Cell International Company Profile
Cryo-Cell International, Inc is a biotechnology and healthcare services company focused on the collection, processing, testing and long-term storage of umbilical cord blood and cord tissue. The company provides families with access to private stem cell banking services intended to preserve potentially valuable biological material for future medical use.
Its services generally include coordinating the collection of cord blood and tissue at birth, transporting specimens to its processing facilities, isolating and cryopreserving stem cells, and maintaining the stored materials under controlled conditions.